Sign In
Buy MYOK
$224.91
+0 (+0%)
At Close: May 27, 2022
MyoKardia Surges After Heart Drug Clears Late-Stage Hurdle
02:42pm, Monday, 11'th May 2020
(Bloomberg) -- MyoKardia Inc. jumped on Monday after its experimental treatment for a rare heart condition met its primary goal and all secondary targets in a key study, delivering a win for the now $
MyoKardia, Inc. (MYOK) today announced positive topline data from the company’s Phase 3 pivotal EXPLORER-HCM clinical trial of mavacamten for the treatment of patients with symptomatic, obstructive
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.45%
12:00am, Monday, 11'th May 2020
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.45%
MyoKardia Reports First Quarter 2020 Financial Results
08:05pm, Wednesday, 06'th May 2020
BRISBANE, Calif., May 06, 2020 -- MyoKardia, Inc. (Nasdaq: MYOK), today reported financial results for the first quarter ended March 31, 2020. “Our team has continued to drive.
Unproven Upside Potential For MyoKardia's Mavacamten
04:34pm, Monday, 04'th May 2020
Mavacamten’s Phase III trial in obstructive hypertrophic cardiomyopathy (oHCM) is likely to meet its primary endpoint, but we believe the market has priced in m
Zacks: Analysts Anticipate Myokardia Inc (NASDAQ:MYOK) Will Post Earnings of -$1.38 Per Share
08:00am, Wednesday, 29'th Apr 2020
Equities research analysts expect Myokardia Inc (NASDAQ:MYOK) to report ($1.38) earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have provided estimates for Myokardia’s
First-Mover Pandemic Disease Fight ETF On The Way
02:35pm, Tuesday, 28'th Apr 2020
Pacer Financial has filed for Pacer BioThreat ETF to enjoy the first-mover advantage that provide investors an option to capitalize on the new opportunities triggered by coronavirus.
First-Mover Pandemic Disease Fight ETF On The Way
02:35pm, Tuesday, 28'th Apr 2020
Pacer Financial has filed for Pacer BioThreat ETF to enjoy the first-mover advantage that provide investors an option to capitalize on the new opportunities triggered by coronavirus.
Investors Buy Large Volume of Myokardia Put Options (NASDAQ:MYOK)
05:22am, Saturday, 25'th Apr 2020
Myokardia Inc (NASDAQ:MYOK) saw some unusual options trading activity on Thursday. Stock traders bought 7,598 put options on the company. This is an increase of approximately 1,948% compared to the ty
Myokardia Target of Unusually High Options Trading (NASDAQ:MYOK)
05:12am, Friday, 24'th Apr 2020
Myokardia Inc (NASDAQ:MYOK) saw some unusual options trading on Thursday. Stock investors acquired 9,777 call options on the stock. This is an increase of approximately 1,691% compared to the average
MyoKardia (MYOK) Received its Third Buy in a Row
05:43pm, Thursday, 23'rd Apr 2020
After BMO Capital and Cantor Fitzgerald gave MyoKardia (NASDAQ: MYOK) a Buy rating last month, the company received another Buy, this time from Credit
MyoKardia (MYOK) Received its Third Buy in a Row
05:43pm, Thursday, 23'rd Apr 2020
After BMO Capital and Cantor Fitzgerald gave MyoKardia (NASDAQ: MYOK) a Buy rating last month, the company received another Buy,
Myokardia Inc (NASDAQ:MYOK) Short Interest Down 6.6% in March
10:04am, Thursday, 23'rd Apr 2020
Myokardia Inc (NASDAQ:MYOK) was the target of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 4,980,000 shares, a decrease of 6.6% from the Marc
Myokardia (NASDAQ:MYOK) Trading Down 5.8% on Insider Selling
05:24am, Wednesday, 22'nd Apr 2020
Myokardia Inc (NASDAQ:MYOK) dropped 5.8% on Tuesday following insider selling activity. The company traded as low as $60.63 and last traded at $62.07, approximately 970,391 shares were traded during t
Exane Derivatives Takes $84,000 Position in Myokardia Inc (NASDAQ:MYOK)
09:46am, Tuesday, 21'st Apr 2020
Exane Derivatives acquired a new stake in shares of Myokardia Inc (NASDAQ:MYOK) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange C
